Huxley Medical AI Platform
AI-powered pathology and laboratory diagnostics solution
Company profile
Company profile
Huxley Medical operates in the Pathology & Laboratory Diagnostics sector. The company's website provides minimal publicly accessible information about its specific offerings, technology platform, or market positioning. Without detailed content from the homepage or additional pages, it is not possible to provide a comprehensive overview of the company's mission, products, clinical focus areas, or the healthcare stakeholders it serves. The company may be in early stages of development, operating in stealth mode, or maintaining a private profile with limited public-facing information. Further investigation through alternative sources would be needed to establish a complete company profile.
Company description Huxley Medical official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
No customer types are currently listed.
Cloud Saas deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered pathology and laboratory diagnostics solution
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · May 26, 2026
Noninvasive Hemodynamic Assessment by a Sensor Patch: The PATCHWRK (PortAble TeCHnology for Wireless caRdiomyopathy tracKing) Study.JACC. Advances · May 1, 2025
Multidiagnostic chest-worn patch to detect obstructive sleep apnea and cardiac arrhythmias.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · May 1, 2025
Polysomnography validation of SANSA to detect obstructive sleep apnea.Frontiers in neurology · Jan 1, 2025
Pan-cancer atlas of tumor-resident microbiome, immunity and prognosis.Cancer letters · Aug 28, 2024
At-home wireless monitoring of acute hemodynamic disturbances to detect sleep apnea and sleep stages via a soft sternal patch.Science advances · Dec 24, 2021
Clinical validation
NCT06070389 · Sponsor · COMPLETED
12 Lead ECG DatabaseNCT06513637 · Sponsor · NOT YET RECRUITING
Electrocardiogram (ECG) Validation StudyNCT06414447 · Sponsor · UNKNOWN
Regulatory
K252497 · 510k · Dec 10, 2025
SANSA HSATK250882 · 510k · Oct 29, 2025
SANSA HSATK244027 · 510k · Jan 28, 2025
Huxley SANSA Home Sleep Apnea Test (1000-00)K240285 · 510k · Jul 15, 2024
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Huxley Medical's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.